Body mass index does not influence loss of response to tumor necrosis factor inhibitors in Crohn's disease Carla Bortolin Fonseca; Roberta Petry; Luciana Harlacher; Laryssa Hanauer; Carlos Fernando Magalhães Francesconi; Paulo Gustavo Kotze; Cristina Flores;

Infliximab en enfermedad inflamatoria intestinal. ¿Es necesario premedicar? Paulina Nuñez F.; Rodrigo Quera; Daniela Simian; Lilian Flores; Carolina Figueroa; Patricio Ibañez; Udo Kronberg; Jaime Lubascher; Gonzalo Pizarro;

Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes Carles Iniesta-Navalón; Lorena Rentero-Redondo; Rosa Gómez-Espín; Manuel Ríos Saorín; Isabel Nicolás de Prado; Juan José Gascón-Cánovas;